Discussion about this post

User's avatar
Gavin Giovannoni's avatar

Just to make the point that this patient would not be eligible for HSCT in the UK. However, he will be eligible for alemtuzumab or cladribine based on the criteria that were used to make the decision about starting natalizumab.

Expand full comment
Vincentina's avatar

Very interesting. Good to know about brain volumn and how it's measured . Thanks for the comments. My neurologist probably inwardly groans when I say I've been reading from Prof G ....

Expand full comment
8 more comments...

No posts